Skip to main content

Share story

AI Products

Meta says AI glasses users will get visual-data opt-out

Meta says it will let users of its AI glasses opt out of having their visual data used to train its AI or shown to third-party contractors outside the United States, Engadget reported. The change would give users a choice over those two uses of visual data collected through the glasses. Meta described the control as a forthcoming option; the reported scope is visual data and contractors outside the United States.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Techmeme and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Robotics Capital
Robotics Capital

GenRobot AI raises $100 million for robot training data infrastructure

Beijing-based GenRobot AI has completed a $100 million Series A+ funding round, TechNode reported. The company develops equipment and software that collect human demonstrations for use in training robots, providing data infrastructure for companies developing robots.

AI Infrastructure
AI Infrastructure

Builder runs Kimi K3 on CPU with discontinued Optane memory

A home server builder ran Moonshot AI's 2.8-trillion-parameter Kimi K3 model without a GPU, using discontinued Intel Optane PMem 200 memory and a 40-core Xeon processor, Tom's Hardware reported.

Science
Science

Phase 3 retatrutide trials report weight loss and reduced knee pain

Two Northwestern University-led Phase 3 trials involving more than 1,000 adults found that participants receiving high doses of Eli Lilly's experimental retatrutide lost, on average, up to 25% of their body weight.

AI Products
AI Products

Apple tests development process giving engineers 50% more coding time

Apple is experimenting with a software development process that gives engineers 50% more time to code and explore while reducing time spent on integration, 9to5Mac reported, citing Bloomberg's Mark Gurman. The experiment comes as coding agents have improved.